AACR 2009: Combined Inhibition of Histone Deacetylase and mTOR: A Novel Therapeutic Approach for Pancreatic Cancer
30 Apr 2009
AACR 2009: Combined Inhibition of Histone Deacetylase and mTOR: A Novel Therapeutic Approach for Pancreatic Cancer
Bacteria as agents to initiate potent anti-tumour activity
ECCO 15 - ESMO 34 Executive Scientific Programme Committee
Flinders University, Australia
University Hospital Gasthuisberg
Results of the new Cetuximab studies in mCRC, from ASCO 2008
Cetuximab for metastatic colorectal cancer (mCRC), from ASCO 2008